SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-11
👔
RIGEL PHARMACEUTICALS INC
@RIGL_InsiderForm 4 Filing: HANNAH ALISON L. Acquires (Grant) shares of $RIGL
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
RIGEL PHARMACEUTICALS INC
Ticker: $RIGL
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-08
Shares: 24,400
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HANNAH ALISON L., holds the title of EVP, Chief Medical Officer at RIGEL PHARMACEUTICALS INC.
On 2026-07-08, the insider transacted 24,400 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
HANNAH ALISON L. (EVP, Chief Medical Officer) was granted $0 of $RIGL
Post-Transaction Position: 35,025 shares
SEC Accession No: 0000905148-26-003238 (CIK: 1645600)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.